Patient's Perception in Symptoms Related to Morning Activity Based on Chronic Obstructive Lung Disease (SYMBOL)

AstraZeneca

Status: Completed

Conditions: COPD

Study type: Observational

Funder types: Industry

Identifiers

NCT00894426

NIS-RKR-DUM-2009/1

Details and patient eligibility

About

The aim of this study is to assess the perception of chronic obstructive pulmonary disease (COPD) patients in symptoms related to morning activities. Also the researchers investigated how to describe the impact of symptoms on sleep quality and how to use the medication in Korea COPD treatments.

Enrollment: 150 estimated patients

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• COPD outpatients over 45 years old
• Lung function: post-FEV1 < 50%
• Current or ex-smoker > 10 packs per year
• Patients who were not on medication of ISC/FC at least 2 weeks

Exclusion criteria

• Ongoing exacerbation of COPD or within the previous 3 months
• History of asthma or allergic rhinitis
• Lung cancer or any other significant respiratory disease such as bronchiectasis, lung fibrosis, interstitial lung disease, tuberculosis, sarcoidosis
• Current participation in an interventional clinical trial

Trial design

150 participants in 2 patient groups

1

Description:

Morning Symptoms (+)

2

Description:

Morning Symptoms (-)